Drug Injury Watch: Fall 2012: Two Recent Medical Reports Regarding Safety Of Pradaxa, Boehringer Ingelheim's Anticoagulation Drug

more+
less-

Drug Injury Watch: Fall 2012: Two Recent Medical Reports Regarding Safety Of Pradaxa, Boehringer Ingelheim's Anticoagulation Drug

Use Of Pradaxa After ACS Is Associated With Increased Rate Of Major Bleeding, And Concomitant Use Of Pradaxa With Multaq Is Contraindicated

http://www.drug-injury.com/druginjurycom/2012/09/pradaxa-associated-with-increased-bleeding-after-acs-chmp-contraindicaton-multaq.html

LOADING PDF: If there are any problems, click here to download the file.